Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

BUY
$36.95 - $82.41 $18,585 - $41,452
503 Added 11.27%
4,966 $225,000
Q1 2022

May 03, 2022

BUY
$55.7 - $145.79 $78,202 - $204,689
1,404 Added 45.9%
4,463 $340,000
Q4 2021

Feb 01, 2022

BUY
$135.05 - $182.59 $63,068 - $85,269
467 Added 18.02%
3,059 $456,000
Q3 2021

Oct 08, 2021

SELL
$145.58 - $192.14 $18,488 - $24,401
-127 Reduced 4.67%
2,592 $377,000
Q2 2021

Aug 05, 2021

BUY
$134.22 - $202.37 $56,372 - $84,995
420 Added 18.27%
2,719 $532,000
Q1 2021

Apr 14, 2021

BUY
$140.25 - $196.86 $264,090 - $370,687
1,883 Added 452.64%
2,299 $416,000
Q1 2021

Apr 13, 2021

BUY
$140.25 - $196.86 $58,344 - $81,893
416 New
416 $75,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.42B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track F Dx Advisors, Inc. Portfolio

Follow F Dx Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.